Autologous Mesenchymal Stem Cells (MSC) for intracavernous injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous Mesenchymal Stem Cells (MSC) for intracavernous injection, covering 2026-02-09 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously [Phase 2]